Alterations in , , , and Genes in a Case of Late-Onset Massive Tumoral Calcinosis.

BACKGROUND/OBJECTIVE: Tumoral calcinosis (TC) is a rare, arcane, and debilitating disorder of phosphate metabolism manifesting as hard masses in soft tissues. Primary hyperphosphatemic TC has been shown to be caused by pathogenic variants in the genes encoding FGF23, GALNT3, and KLOTHO. We report a case of massive TC mechanistically associated with phosphatonin resistance associated with heterozygous alterations in the sterile alfa motif domain-containing protein-9 gene (), alfa 2-Heremans-Schmid glycoprotein gene (), FSHD region gene 2-family member-C gene (), and fibroblast growth factor receptor-4 gene ().

CASE REPORT

A middle-aged Malay woman with systemic sclerosis presented with painful hard lumps of her axillae, lower limbs, and external genitalia. She was eucalcemic with mild hyperphosphatemia associated with reduced urinary phosphate excretion. Magnetic resonance imaging revealed calcified soft tissue masses. Paradoxically, the serum intact FGF23 level increased to 89.6 pg/mL, corroborated by Western blots, which also showed overexpression of sFRP4 and MEPE, consistent with phosphatonin resistance.

DISCUSSION

Whole genome sequencing identified 2 heterozygous alterations (p.A454T and p.T479M) in , 2 heterozygous alterations (p.M248T and p.S256T) in , a frameshift alteration (p.Arg156fs) in , and a heterozygous alteration (p.G388R) in , all of which are associated with calcinosis. Nonsynonymous alterations of and were also detected.

CONCLUSION

This highlights that the simultaneous occurrence of alterations in several genes critical in phosphate homeostasis may trigger massive TC despite their heterozygosity. These findings should prompt functional studies in cell and animal models to reveal mechanistic insights in the pathogenesis of such crippling mineralization disorders.